In The News
Designing and Building the Path to Life Sciences Advancement
It’s certainly an understatement to say that the life science industry is experiencing unprecedented demands for speed within discovery, development, and manufacturing. Add to this the explosive growth in new therapies and technologies and it presents a daunting task. Yet, the industry is rising to meet the challenge. In doing so, they also need to find the fastest, safest, most effective way to make their mission possible. That’s where Genesis AEC comes in, providing expert consulting; architecture; engineering; construction management; asset management; and commissioning, qualification, and validation services.
Founded in 1996, Genesis was rooted in a fundamental understanding that the quality of engineering service offered by other AEC firms didn’t meet the needs and expectations of life science companies. That focus has fueled the demand for Genesis’ services, driving organic growth. In the last 10 years alone, they have more than quadrupled in size – adding people, services, and offices, while never compromising quality.
Genesis has transitioned from a small regional company to a national AEC firm with more than 300 talented professionals who serve clients coast-to-coast from offices in Pennsylvania, Massachusetts, and California. In their 25-year history, they have completed nearly 8,000 projects including cell and gene therapies, R&D laboratories, bulk biologics, OSD, sterile fill/finish, QA/QC laboratories, clinical manufacturing, facility infrastructure, and more. “While the size, quantity, and complexity of our projects has changed over the years, our dedication and commitment to life science institutions and the patients they serve hasn’t wavered,” says Norman Goldschmidt, President of Genesis AEC.
The Genesis Way
Responding to “why Genesis?” Norm, an industry veteran with more than 30 years of experience in planning, design; construction, validation and compliance consulting responded, “Our team understands the industry and in turn, the challenges our clients face. I worked in an operating biopharmaceutical company for 20 years, and I’m not alone. Many of our staff have been worked in operating companies, giving us an appreciation for our client’s challenges. We take time to listen, to problem-solve, to add value as a seamless member of their team. By viewing their challenges through our eyes, we are better able to develop the compliant and efficient workflows that best serve patients and businesses. It’s that connection, an understanding of our client’s mission and challenges – a shared sense of purpose – that sets Genesis apart.”
In an employee survey, the Genesis team expressed their pride for the quality work the company delivers; their appreciation for being able to support a variety of projects from cGMP facility expansions and renovations for global pharma leaders to design-build projects for emerging biotech start-ups; and their passion for making a difference in the world at-large. “That matters because our business is built on trust and relationships. And you earn that trust by being a professional, being knowledgeable about what you do, and being dependable and authentic. Our team exemplifies those qualities in what we define as “The Genesis Way,” affirms Norm.
The team’s dedication to listen and their willingness to ‘go the extra mile’ shows in the quality of their work. Clients appreciate how the team blends into their culture with integrity and adaptability. A confidential client reiterates this, “They became an extension of our group. They listened well, and they ‘played well with others.’ They knew what they were talking about, and I can’t stress that enough.”
“I think what makes us unique is that we care about the work we do, and our clients can see that every step of the way. We’re able to deliver value clients wouldn’t receive from other firms, by always keeping line-of-sight to the patient,” says Norm.
For a Better Future
Genesis aims to be the preferred partner for its clients – and their progress towards that goal is impressive. Genesis ranks fifth in pharmaceutical design by Engineering News-Record (ENR) magazine. The company is consistently ranked as a Zweig Group Hot Firm.
To keep pace with the industry’s rapid growth, they will be opening new offices in life sciences hubs across the country. “For Genesis, the key is managed growth, making a concerted effort to ensure we maintain our quality, our culture, and client service, yet continuing our steady expansion into new markets as patients, companies, and institutions need us,” concludes Norm.
Originally published by The Healthcare Insights
- Cell and Gene Therapies: Medical therapies that involve altering the genes inside a person’s cells to treat or cure disease.
- R&D Laboratories: Research and Development laboratories where scientific research is conducted.
- Bulk Biologics: Large-scale production of biologically active substances.
- OSD: Oral Solid Dosage, a form of medication.
- Sterile Fill/Finish: The process of filling and sealing sterile pharmaceuticals or biologics into their final container.
- QA/QC Laboratories: Quality Assurance/Quality Control laboratories that ensure products meet certain standards and specifications.
- cGMP: Current Good Manufacturing Practices, a set of regulations enforced by the FDA for the manufacturing of pharmaceuticals.